Wolverine Trading’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.13M | Sell |
76,100
-36,100
| -32% | -$1.41M | ﹤0.01% | 1783 |
|
|
2025
Q2 | $4.33M | Buy |
112,200
+19,200
| +21% | +$734K | ﹤0.01% | 1148 |
|
|
2025
Q1 | $3.6M | Buy |
93,000
+39,400
| +74% | +$1.44M | ﹤0.01% | 1206 |
|
|
2024
Q4 | $1.8M | Sell |
53,600
-25,300
| -32% | -$911K | ﹤0.01% | 2057 |
|
|
2024
Q3 | $3.21M | Buy |
+78,900
| New | +$3.23M | ﹤0.01% | 1349 |
|
|
2024
Q2 | – | Sell |
-95,500
| Closed | -$4.09M | – | 4767 |
|
|
2024
Q1 | $4.09M | Sell |
95,500
-16,900
| -15% | -$697K | ﹤0.01% | 1134 |
|
|
2023
Q4 | $4.17M | Buy |
112,400
+9,800
| +10% | +$352K | ﹤0.01% | 1217 |
|
|
2023
Q3 | $3.72M | Sell |
102,600
-45,300
| -31% | -$1.61M | ﹤0.01% | 1174 |
|
|
2023
Q2 | $5.24M | Buy |
147,900
+17,900
| +14% | +$642K | 0.01% | 877 |
|
|
2023
Q1 | $4.58M | Sell |
130,000
-6,600
| -5% | -$231K | 0.01% | 882 |
|
|
2022
Q4 | $4.8M | Sell |
136,600
-4,800
| -3% | -$160K | 0.01% | 921 |
|
|
2022
Q3 | $4.15M | Buy |
+141,400
| New | +$5.36M | 0.01% | 945 |
|
|
2022
Q2 | – | Sell |
-63,440
| Closed | -$3.46M | – | 4985 |
|
|
2022
Q1 | $3.46M | Sell |
63,440
-159,120
| -71% | -$8.64M | ﹤0.01% | 1321 |
|
|
2021
Q4 | $12.3M | Buy |
222,560
+161,520
| +265% | +$8.4M | 0.01% | 635 |
|
|
2021
Q3 | $2.92M | Sell |
61,040
-21,440
| -26% | -$1.08M | ﹤0.01% | 1752 |
|
|
2021
Q2 | $4.12M | Sell |
82,480
-11,120
| -12% | -$534K | 0.01% | 1322 |
|
|
2021
Q1 | $4.25M | Buy |
93,600
+29,920
| +47% | +$1.36M | 0.01% | 1256 |
|
|
2020
Q4 | $2.95M | Buy |
63,680
+31,440
| +98% | +$1.44M | ﹤0.01% | 1415 |
|
|
2020
Q3 | $1.51M | Sell |
32,240
-22,560
| -41% | -$1.13M | ﹤0.01% | 1692 |
|
|
2020
Q2 | $2.79M | Sell |
54,800
-18,000
| -25% | -$923K | 0.01% | 1166 |
|
|
2020
Q1 | $3.42M | Sell |
72,800
-960
| -1% | -$51.2K | 0.01% | 968 |
|
|
2019
Q4 | $4.34M | Sell |
73,760
-41,440
| -36% | -$2.31M | 0.01% | 1210 |
|
|
2019
Q3 | $6.1M | Buy |
115,200
+45,840
| +66% | +$2.36M | 0.02% | 754 |
|
|
2019
Q2 | $3.47M | Sell |
69,360
-38,240
| -36% | -$1.92M | 0.01% | 1141 |
|
|
2019
Q1 | $5.62M | Buy |
107,600
+20,000
| +23% | +$999K | 0.02% | 812 |
|
|
2018
Q4 | $4.18M | Sell |
87,600
-8,480
| -9% | -$418K | 0.01% | 925 |
|
|
2018
Q3 | $4.82M | Buy |
96,080
+19,920
| +26% | +$1.01M | 0.01% | 999 |
|
|
2018
Q2 | $3.72M | Hold |
76,160
| – | – | 0.01% | 1105 |
|
|
2018
Q1 | $3.72M | Buy |
76,160
+34,960
| +85% | +$1.63M | 0.01% | 1105 |
|
|
2017
Q4 | $1.83M | Sell |
41,200
-1,520
| -4% | -$70.2K | 0.01% | 1632 |
|
|
2017
Q3 | $2.17M | Buy |
42,720
+5,520
| +15% | +$280K | 0.01% | 1272 |
|
|
2017
Q2 | $2.01M | Sell |
37,200
-5,600
| -13% | -$299K | 0.01% | 1233 |
|
|
2017
Q1 | $2.27M | Sell |
42,800
-35,680
| -45% | -$1.81M | 0.01% | 1100 |
|
|
2016
Q4 | $3.78M | Buy |
78,480
+6,400
| +9% | +$316K | 0.02% | 900 |
|
|
2016
Q3 | $3.87M | Sell |
72,080
-77,200
| -52% | -$4.23M | 0.02% | 896 |
|
|
2016
Q2 | $7.92M | Buy |
+149,280
| New | +$7.86M | 0.04% | 441 |
|
Other funds holding GSK
JEST
Wolverine Trading's GSK Position: Q2 2025 in Review
Wolverine Trading sold out of GSK (GSK) in Q2 2025, closing a stake of 37,079 shares — an estimated $1.42M sold.
Wolverine Trading first reported a position in GSK in Q2 2016 and held it in 29 quarters. The position peaked at $3.41M in Q4 2021. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.
- Wolverine Trading reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
- Wolverine Trading sold 37,079 GSK shares in Q2 2025, an estimated $1.42M.
- Wolverine Trading first reported a position in GSK in Q2 2016 and held it in 29 quarters.
- Wolverine Trading's GSK position peaked at $3.41M in Q4 2021.
- 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.
Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.